Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial symbols : SRDX save search
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
Published: 2023-11-16 (Crawled : 15:30) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: 0.0%
H: 1.21%
C: 0.62%
trial
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
Published: 2023-11-07 (Crawled : 13:00) - biospace.com/
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: 0.69%
H: 1.71%
C: 0.95%
symposium trial transcend
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
Published: 2023-11-07 (Crawled : 13:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: 0.69%
H: 1.71%
C: 0.95%
symposium trial
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
Published: 2023-01-16 (Crawled : 15:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
| Email alert
Add to watchlist
conference trial
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
Published: 2022-11-17 (Crawled : 14:20) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: -1.31%
H: 0.81%
C: -1.17%
trial
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
Published: 2022-11-11 (Crawled : 14:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: -0.69%
H: 4.6%
C: 1.3%
trial
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
Published: 2022-11-02 (Crawled : 13:00) - biospace.com/
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.58%
H: 2.53%
C: -0.7%
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: -0.77%
H: 8.9%
C: 4.92%
conference trial transcend
First Round of Late-Breaking Clinical Trial Results Announced at VIVA22
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: -0.21%
H: 0.76%
C: -0.26%
viva22 trial results
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: 0.14%
H: 1.46%
C: 0.34%
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: 1.29%
H: 3.22%
C: 1.97%
trial transcend
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
Published: 2022-10-11 (Crawled : 13:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: -0.63%
H: 3.43%
C: 1.64%
europe trial
12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021 Event
Published: 2021-01-25 (Crawled : 20:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: -0.9%
trial
Surmodics Announces TRANSCEND Trial 12-Month Data to be Presented at LINC 2021 Virtual Event
Published: 2021-01-12 (Crawled : 15:00) - biospace.com/
SRDX | $25.32 -4.42% -4.62% 120K
|
Health Technology
|
| O: 0.62%
H: 6.67%
C: 6.03%
trial
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.